0001213900-21-024716.txt : 20210505
0001213900-21-024716.hdr.sgml : 20210505
20210505170031
ACCESSION NUMBER: 0001213900-21-024716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210505
DATE AS OF CHANGE: 20210505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASAMENTO CHARLES J
CENTRAL INDEX KEY: 0001117167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39082
FILM NUMBER: 21894311
MAIL ADDRESS:
STREET 1: 99 BELBROOK WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001553643
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455401931
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646 876 3459
MAIL ADDRESS:
STREET 1: 880 3RD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CAMP NINE, INC.
DATE OF NAME CHANGE: 20120706
4
1
ownership.xml
X0306
4
2021-05-03
0
0001553643
RELMADA THERAPEUTICS, INC.
RLMD
0001117167
CASAMENTO CHARLES J
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR
NEW YORK
NY
10022
1
0
0
0
Common Stock
2021-05-03
4
S
0
3000
38.2157
D
9950
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
Sales prices range from $37.94 to $38.94 per share, inclusive.
/s/ Charles J. Casamento
2021-05-05